Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial.

H, Liu; Z, Zeng; H, Zhang; M, Wu; D, Ma; Q, Wang; M, Xie; Q, Xu; J, Ouyang; Y, Xiao; Y, Song; B, Feng; Q, Xu; Y, Wang; Y, Zhang; Y, Hao; S, Luo; X, Zhang; Z, Yang; J, Peng; X, Wu; D, Ren; M, Huang; P, Lan; W, Tong; M, Ren; J, Wang; L, Kang

doi:10.1097/sla.0000000000005523

Public

Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial.

Shared by NobleBlocks on Jul 11, 2022 • 12:00 AM UTC

Authors:

Liu H

Zeng Z

Zhang H

Abstract

Objective To determine the morbidity, mortality, and pathologic outcomes of transanal total mesorectal resection (taTME) versus laparoscopic total mesorectal excision (laTME) among patients with rectal cancer with clinical stage I to III rectal cancer below the peritoneal reflection.Background Studi...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!